Cell-specific cross-talk proteomics reveals cathepsin B signaling as a driver of glioblastoma malignancy near the subventricular zone.
Emily S NortonLauren A WhaleyVanessa K JonesMieu M BrooksMarissa N RussoDmytro MordererErik JessenPaula SchiapparelliAndres Ramos-FresnedoNatanael ZarcoAnna CarranoWilfried RossollYan W AsmannTukiet T LamKaisorn L ChaichanaPanos Z AnastasiadisAlfredo Quiñones-HinojosaHugo Guerrero-CazaresPublished in: Science advances (2024)
Glioblastoma (GBM) is the most prevalent and aggressive malignant primary brain tumor. GBM proximal to the lateral ventricles (LVs) is more aggressive, potentially because of subventricular zone contact. Despite this, cross-talk between GBM and neural stem/progenitor cells (NSC/NPCs) is not well understood. Using cell-specific proteomics, we show that LV-proximal GBM prevents neuronal maturation of NSCs through induction of senescence. In addition, GBM brain tumor-initiating cells (BTICs) increase expression of cathepsin B (CTSB) upon interaction with NPCs. Lentiviral knockdown and recombinant protein experiments reveal that both cell-intrinsic and soluble CTSB promote malignancy-associated phenotypes in BTICs. Soluble CTSB stalls neuronal maturation in NPCs while promoting senescence, providing a link between LV-tumor proximity and neurogenesis disruption. Last, we show LV-proximal CTSB up-regulation in patients, showing the relevance of this cross-talk in human GBM biology. These results demonstrate the value of proteomic analysis in tumor microenvironment research and provide direction for new therapeutic strategies in GBM.
Keyphrases
- single cell
- endothelial cells
- cell therapy
- end stage renal disease
- mass spectrometry
- ejection fraction
- dna damage
- newly diagnosed
- stem cells
- chronic kidney disease
- cerebral ischemia
- prognostic factors
- gene expression
- stress induced
- peritoneal dialysis
- blood brain barrier
- small molecule
- label free
- binding protein
- protein protein